Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins

Journal Title: Women's Health – Open Journal - Year 2017, Vol 3, Issue 1

Abstract

The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasingly taking a center stage among biotherapeutics. The technologies of glycoengineering are making a further impact by modifying the glycan moieties, which make them biologically more active and increase their effectiveness and pharmacokinetics, etc. Human Chorionic Gonadotropin (hCG) has been used in reproductive medicine for the last several decades. The paradigm shift on the hCG actions has created additional therapeutic opportunities against many menacing and dangerous diseases that are no less important than the ones treated by some of the prominent members of the therapeutic glycoproteins family. However, to the best of the authors’ knowledge, hCG has never been included in this family or tapped the potential of glycoengineering to make hCG even more therapeutically effective than the currently used preparations. It is time to include hCG in the family and begin glycoengineering on recombinant hormone.

Authors and Affiliations

C. V. Rao

Keywords

Related Articles

Development and Significance of “Mamin”: A Child-Care Record-Keeping Mobile Application for Parents

Many studies have indicated that early detection, early intervention and treatment lead to a favorable prognosis for child illnesses and disabilities, the slightest signs of which, in reality, are often overlooked. There...

Potential Efficacy of Anti-PD-1 or PD-L1 Antibody Treatments for Gynecologic Cancers

Programmed cell death-1 (PD-1; CD279) is an immunosuppressive co-inhibitory molecule that belongs to the CD28 family of receptors on T-cells. It was discovered by Ishida et al in 1992.1 The most important peripheral regu...

Perception of Fatigue in Female Nurses Employed in Hospitals

Background: Fatigue is the inability to maintain the required stamina in work capacity with consequences affecting occupational performance, health, and safety. Women are often more exposed to the risk of fatigue because...

Endometriosis and Epigenetics: What do we Know?

Objective Endometriosis is a common gynecological condition with a pathogenesis that is multifactorial and not well understood. The aim of this review was to explore the multiplicity of epigenetic changes in the field of...

Iron Deficiency in Women

It is a well known fact that anaemia can give rise to a range of problems for people who suffer from it.1 In what follows, I will be concentrating on elaborating some of the subtle health issues surrounding anaemia. Anae...

Download PDF file
  • EP ID EP554903
  • DOI 10.17140/WHOJ-3-119
  • Views 142
  • Downloads 0

How To Cite

C. V. Rao (2017). Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins. Women's Health – Open Journal, 3(1), 30-35. https://europub.co.uk/articles/-A-554903